Skip to Content
Merck

C6239

Cinalukast

~98% (HPLC)

Synonym(s):

(E)-4-[[3-(2-(4-Cyclobutyl-2-thiazolyl)ethenyl)phenyl]amino]-2,2-diethyl-4-oxobutanoic acid, Ro 24-5913

Slide 1 of 1
Sign In to View Organizational & Contract Pricing.

Select a Size

C6239-5MG

PLN 727.00

PLN 727.00

Please contact Customer Service for Availability
​
Request a Bulk Order

About This Item

Empirical Formula (Hill Notation):
C23H28N2O3S
CAS Number:
128312-51-6
Molecular Weight:
412.55
NACRES:
NA.77
PubChem Substance ID:
24724447
UNSPSC Code:
12352202
MDL number:
MFCD00864778
Assay:
~98% (HPLC)
Form:
solid
Quality level:
100

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

assay

~98% (HPLC)

Quality Level

100

form

solid

color

off-white

solubility

DMSO: >10 mg/mL, H2O: insoluble

originator

Roche

storage temp.

2-8°C

SMILES string

CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(O)=O

InChI

1S/C23H28N2O3S/c1-3-23(4-2,22(27)28)14-20(26)24-18-10-5-7-16(13-18)11-12-21-25-19(15-29-21)17-8-6-9-17/h5,7,10-13,15,17H,3-4,6,8-9,14H2,1-2H3,(H,24,26)(H,27,28)/b12-11+

InChI key

BZMKNPGKXJAIDV-VAWYXSNFSA-N

Gene Information

human ... CYSLTR1(10800)

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
SML2695SML2547SML2281
Cinalukast ~98% (HPLC)

Sigma-Aldrich

C6239

Cinalukast

FB23 ≥98% (HPLC)

Sigma-Aldrich

SML2695

FB23

KCC-07 ≥98% (HPLC)

Sigma-Aldrich

SML2547

KCC-07

BAY 60-2770 ≥98% (HPLC)

Sigma-Aldrich

SML2281

BAY 60-2770

form

solid

form

powder

form

powder

form

powder

assay

~98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

Quality Level

100

Quality Level

100

Quality Level

-

Quality Level

-

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

solubility

DMSO: >10 mg/mL, H2O: insoluble

solubility

DMSO: 2 mg/mL, clear

solubility

DMSO: 2 mg/mL, clear

solubility

DMSO: 2 mg/mL, clear

originator

Roche

originator

-

originator

-

originator

-

Biochem/physiol Actions

Specific CysLT1 leukotriene receptor antagonist.

Features and Benefits

This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
083K4616

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Studies of the combination of Ro 24-5913, a peptidoleukotriene antagonist, and Ro 24-4736, a PAF antagonist, in guinea pig and rat models of lung inflammation.
A F Welton et al.
Annals of the New York Academy of Sciences, 744, 274-288 (1994-11-15)
H Maehr et al.
Bioorganic & medicinal chemistry, 5(3), 493-496 (1997-03-01)
Structure optimization of the leukotriene D4 antagonist Ro24-5913 was attempted by combinatorial chemistry. Three segments in its N-succinyl-3-(2-thiazolylethenyl)anilide skeleton, designated as A, B, and C coincided with the thiazolyl, aniline, and N-acyl moieties, respectively, and were selected for variations in
Michael Föller et al.
European journal of clinical investigation, 40(6), 534-540 (2010-05-12)
Fever and hyperthermia are frequently associated with anaemia. Under most clinical conditions, they are considered to be two mutually independent clinical consequences of a common cause. The present study explored the possibility that anaemia results from temperature-sensitive suicidal erythrocyte death
G E Rovati et al.
Biochemical pharmacology, 44(7), 1411-1415 (1992-10-06)
We have identified and characterized two different subclasses of binding site for the novel peptido-leukotriene (LT) antagonist, [3H]ICI 198,615, in membranes from human lung parenchyma using a receptor-ligand assay. This novel compound is representative of a new class of LT
Ro 24-5913: a potent, specific, orally active LTD4 antagonist.
M O'Donnell
Annals of the New York Academy of Sciences, 629, 413-415 (1991-01-01)
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service